Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial

被引:2119
作者
Shakur, Haleema [1 ]
Roberts, Ian [1 ]
Bautista, Raul [1 ]
Caballero, Jose [1 ]
Coats, Tim [1 ]
Dewan, Yashbir [1 ]
El-Sayed, Hesham [1 ]
Gogichaishvili, Tamar [1 ]
Gupta, Sanjay [1 ]
Herrera, Jorge [1 ]
Hunt, Beverley [1 ]
Iribhogbe, Pius [1 ]
Izurieta, Mario [1 ]
Khamis, Hussein [1 ]
Komolafe, Edward [1 ]
Marrero, Maria-Acelia [1 ]
Mejia-Mantilla, Jorge [1 ]
Miranda, Jaime [1 ]
Morales, Carlos [1 ]
Olaomi, Oluwole [1 ]
Dashi, Fatos [1 ]
Perel, Pablo [1 ]
Peto, Richard [1 ]
Ramana, P. V. [1 ]
Ravi, R. R. [1 ]
Yutthalcasemsunt, Surakrant [1 ]
Dakubo, Jonathan [1 ]
Gogichaishvili, Tamar [1 ]
Golden, Nyoman [1 ]
Izurieta, Mario [1 ]
Khamis, Hussein [1 ]
Komolafe, Edward [1 ]
Loria-Castellanos, Jorge [1 ]
Mejia-Mantilla, Jorge [1 ]
Miranda, Jaime [1 ]
Munoz, Angeles [1 ]
Mutiso, Vincent [1 ]
Olcwen, Patrick [1 ]
Ortiz, Zulma [1 ]
Pascual, Maria [1 ]
Ravi, R. [1 ]
Roslani, April [1 ]
Trenkler, Stefan [1 ]
Volpi, Annalisa [1 ]
Yutthakasemsunt, Surakrant [1 ]
Roberts, Ian [1 ]
Shakur, Haleema [1 ]
Perel, Pablo [1 ]
Bametson, Lin [1 ]
Ramos, Maria [1 ]
机构
[1] Univ London London Sch Hyg & Trop Med, Clin Trials Unit, London WC1E 7HT, England
关键词
BRAIN-INJURY; EPIDEMIOLOGY;
D O I
10.1016/S0140-6736(10)60835-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Tranexamic acid can reduce bleeding in patients undergoing elective surgery. We assessed the effects of early administration of a short course of tranexamic acid on death, vascular occlusive events, and the receipt of blood transfusion in trauma patients. Methods This randomised controlled trial was undertaken in 274 hospitals in 40 countries. 20 211 adult trauma patients with, or at risk of, significant bleeding were randomly assigned within 8 h of injury to either tranexamic acid (loading dose 1 g over 10 min then infusion of 1 g over 8 h) or matching placebo. Randomisation was balanced by centre, with an allocation sequence based on a block size of eight, generated with a computer random number generator. Both participants and study staff (site investigators and trial coordinating centre staff) were masked to treatment allocation. The primary outcome was death in hospital within 4 weeks of injury, and was described with the following categories: bleeding, vascular occlusion (myocardial infarction, stroke and pulmonary embolism), multiorgan failure, head injury, and other. All analyses were by intention to treat. This study is registered as ISRCTN86750102, Clinicaltrials.gov NCT00375258, and South African Clinical Trial Register DOH-27-0607-1919. Findings 10 096 patients were allocated to tranexamic acid and 10 115 to placebo, of whom 10 060 and 10 067, respectively, were analysed. All-cause mortality was significantly reduced with tranexamic acid (1463 [14.5%] tranexamic acid group vs 1613 [16.0%] placebo group; relative risk 0.91, 95% CI 0.85-0.97; p=0.0035). The risk of death due to bleeding was significantly reduced (489 [4.9%] vs 574 [5.7%]; relative risk 0.85, 95% CI 0.76-0.96; p=0.0077). Interpretation Tranexamic acid safely reduced the risk of death in bleeding trauma patients in this study. On the basis of these results, tranexamic acid should be considered for use in bleeding trauma patients.
引用
收藏
页码:23 / 32
页数:10
相关论文
共 25 条
[1]  
[Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004896
[2]  
[Anonymous], 2010, OXF TXB MED
[3]   Acute coagulopathy of trauma: Hypoperfusion induces systemic anticoagulation and hyperfibrinolysis [J].
Brohi, Karim ;
Cohen, Mitchell J. ;
Ganter, Michael T. ;
Schultz, Marcus J. ;
Levi, Marcel ;
Mackersie, Robert C. ;
Pittet, Jean-Francois .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2008, 64 (05) :1211-1217
[4]   Specific barriers to the conduct of randomized trials [J].
Duley, Lelia ;
Antman, Karen ;
Arena, Joseph ;
Avezum, Alvaro ;
Blumenthal, Mel ;
Bosch, Jackie ;
Chrolavicius, Sue ;
Li, Timoa ;
Ounpuu, Stephanie ;
Perez, Analia Cristina ;
Sleight, Peter ;
Svard, Robbyno ;
Temple, Robert ;
Tsouderous, Yannis ;
Yunis, Carla ;
Yusuf, Salim .
CLINICAL TRIALS, 2008, 5 (01) :40-48
[5]  
Ekbäck G, 2000, ANESTH ANALG, V91, P1124
[6]   Anti-fibrinolytic agents in post partum haemorrhage: a systematic review [J].
Ferrer, Pili ;
Roberts, Ian ;
Sydenham, Emma ;
Blackhall, Karen ;
Shakur, Haleema .
BMC PREGNANCY AND CHILDBIRTH, 2009, 9
[7]  
Fiechtner BK, 2001, ANESTH ANALG, V92, P1131
[8]   Injuries: the neglected burden in developing countries [J].
Gosselin, Richard A. ;
Spiegel, David A. ;
Coughlin, Richard ;
Zirkle, Lewis G. .
BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2009, 87 (04) :246-246
[9]   Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion [J].
Henry, D. A. ;
Carless, P. A. ;
Moxey, A. J. ;
O'Connell, D. ;
Stokes, B. J. ;
McClelland, B. ;
Laupacis, A. ;
Fergusson, D. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (04)
[10]   Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5 [J].
Hogan, Margaret C. ;
Foreman, Kyle J. ;
Naghavi, Mohsen ;
Ahn, Stephanie Y. ;
Wang, Mengru ;
Makela, Susanna M. ;
Lopez, Alan D. ;
Lozano, Rafael ;
Murray, Christopher J. L. .
LANCET, 2010, 375 (9726) :1609-1623